Dr Hugh Spotswood

Hugh SpotswoodPhD

Director, Licensing & Business Development

Life science
Merck KGaA


Research Interests

organ-on-a-chip, 3D models, ADME-Tox, drug safety, CRISPR, organoids

Sigma-Aldrich (subsidiary of Merck KGaA) offer a portfolio of products focused on the testing of drug safety. We leverage our legacy gene editing capabilities to provide knock out cell lines in support of drug testing. I am interested to talk to collaborators/partners in this area.